Applied Nutrition shares rose on Tuesday after the group announced revenues would be ahead of guidance provided at the time of its IPO.
The firm achieved revenue growth of approximately 24% year-on-year for the financial year ending 31 July 2025 with revenues of around £107 million, up from £86 million in the previous year.
The results exceeded market expectations, driven by strong second-half trading of approximately £60 million. Adjusted EBITDA also grew by around 19% year-on-year, whilst net cash reached approximately £18.5 million, ahead of forecasts.
There’s more good news for investors. Applied Nutrition has not only smashed expectations for the last year, but it also expects 2026 revenue to surpass current market expectations.
Shares in the sports nutrition group were 9% higher at the time of writing.
The group said it would continue to focus on its core strengths, including its B2B-focused business model and industry-leading product development capabilities.
Applied Nutrition will release its full-year results on or around 10 November 2025.
“We are proud to report that we have exceeded the guidance we gave at our IPO, with our first full-year results expected to come in ahead of market expectations,” said Thomas Ryder, CEO of Applied Nutrition.
“Our focus and ambition remain as strong as ever – in delivering for our shareholders, customers and team – and we are excited about the opportunities we have in the pipeline for the year ahead.”